Recombinant zoster vaccine well tolerated by patients with inflammatory RMD
Herpes zoster (HZ) is common in older people, with a lifetime risk 25%. The main risk factors are advanced age and immunosupration. People with a rheumatic and musculoskeletal disease have an overall high risk for ringworm. Eular – European alliance of associations for rheumatology – recommends that HZ vaccination is considered with an autoimmune and […]